Focus: Tech’s antitrust woes and money flowing east

The week that was:

On Tuesday the UK began its vaccine program using the Pfizer/BioNTech vaccine. The Moderna and AstraZeneca vaccines may be included later, if and when approved.

The Pfizer/BioNTech vaccine gained overwhelming backing from a panel of government advisors, which clears the way for the United States Food and Drug Administration (FDA) to approve its use, and for the world’s largest economy to start its own vaccine programs at state level.